Document Type : Original Article
- Sara Jalali-Jivan 1
- Shafieh Movassaghi 1
- Seyed Reza Najafizadeh 1
- Abdolrahman Rostamian 2
- Rabeah Rajabzadeh 1
- Hengameh Babaei-Lakeh 3
- Mahroo Mohammad Hoseini 3
- Amirmasoud Kazemzadeh-Houjaghan 4
- Ghazal Behzad 4
1 Department of Rheumatology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2 Department of Rheumatology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Rheumatology Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
3 school of Medicine, Islamic Azad University of Medical science, Tehran, Iran.
4 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease characterized by the inflammatory arthritis rheumatoid
factor (RF: An IgM produced against anti-immunoglobulin G) and anti-cyclic citrullinated peptide (anti-CCP) autoantibodies. In
the present study, the aim was to register RA patients in Imam Khomeini Hospital, Tehran, Iran.
The study population of this research was RA patients referred to the rheumatology clinic in 2019 at Imam Khomeini Hospital in
Tehran and had been diagnosed 5 years ago. Demographic, clinical, and laboratory information of patients at the beginning of
referral at 3 months, and 1, 2, 3, and 4 years after referral, were carefully recorded in each patient questionnaire.
In the first visit, 79 RA patients were examined and in the other 5 visits, 73, 52, 33, 20, 13 patients, respectively, were examined
totalling 270 visits. RF and anti-CCP were positive in 58.22% and 62.02% of patients, respectively. The mean age of patients
was 52.5±11.25 years. The results of the present study showed that the mean morning stiffness, DAS, arthritis, arthralgia, ESR, and
CRP decreased from the second visit through the following five visits which indicated disease control.
Clinical and laboratory data showed considerable disease control, however, relapse of disease was seen due to drug discontinuation.
Registering the disease makes it possible to record the necessary information of each patient, including demographic, clinical, and
paraclinical findings as well as consultations, and gives the physician accurate access to patient information and unnecessary
duplication of paraclinical examinations.